Blog & Resources
Looking for my thoughts on everything from bioethics to movies? You came to the right place. And while you’re here, check out my free downloadable resources.
Sign up to be notified when new posts release.
In the Near Future: Uterus Transplants
The New York Times November 13 print edition ran an article by Denise Grady that announced "Uterus Transplants May Soon Help Some Infertile Women in the U.S. Become Pregnant." The Times considered the news so big that a press release came to my in-box. It's all going down at The Cleveland Clinic, where doctors expect to become the first in the US to transplant a uterus into a woman who lacks one—whether due to congenital factors, injury, or illness. The procedure would eliminate the need for a gestational surrogate.After giving birth to one or two children—by C-section—the woman receiving the transplanted uterus would have it removed so she can quit taking anti-rejection meds. An estimated 50,000 women in the United States might be candidates. Currently, eight have begun the screening process.The transplant team would remove the uterus, cervix, and part of the vagina from a recently deceased organ donor. (The uterus, if kept cold, can survive outside of the human body for six to eight hours.) The recipient's ovaries and fallopian tubes would be left in place, and after one year of healing, she would undergo an IVF/embryo transfer procedure.Sweden is the only place where doctors have already successfully completed uterine transplants. Nine recipients have delivered four babies. Another is due January 2016. Two failed and had to be removed—one, due to a blood clot; the other, due to infection. The Cleveland doctors plan to use deceased donors, so they won't put healthy women at risk. For a live donor, the operation takes seven to eleven hours and requires working near vital organs.Recipients must have ovaries. But because the fallopian tubes won't be connected to the transplanted uterus, a natural pregnancy will be impossible.
Bioethics in the News
Thanks to the Center for Bioethics and Human Dignity for flagging these stories.
Lots of People on Antidepressants (Scientific American) The Mayo Clinic says about 13% of Americans, more than 1 in 10, take an antidepressant. Of women between the ages of 50 and 64, nearly 25% take an antidepressant. (Read More)
No Bucket Challenge for Ebola
A British Surrogate Mother Rejects Her Disabled Twin
Will Stem Cells Replace Heart Operations?
Scientists Have Coached Lab Cells to Make a Working Human Organ
Crime and IVF
No More Reading Glasses in the Future?
Do We Need a Different Approach to Cancer?
Lack of Toilets Puts Women's Health and Safety at Risk
Japanese Man Overdoes It with Surrogacy
Bioethics in the News This Week
AlternativePap Smear Approved (ABC News) US health regulators have okayed a genetic test as a first-choice screening option for cervicalcancer.
Bioethics in the News
Bioethics in the News
Bioethics in the News
Bioethics: Making Headlines
Lots of interesting developments inthe field of bioethics this week. Take a look at these top stories, reported bythe Deerfield, Illinois, Center for Bioethics and Human Dignity:
Most detailed 3D map of human brain Adeceased 65-year-old woman has provided scientists with the material for thefirst super high-resolution, three-dimensional digital model of the humanbrain. (The Telegraph)
FDA approves morning after pill for women of childbearing age TheU.S. Food and Drug Administration approved Plan B emergencycontraceptive without a prescription for all women of childbearing age,officials say. (UPI)
In new tools to combat epidemics, the key is context Now a newproject called BioMosaic is building a more comprehensive picture offoreign-borne disease threats in the United States, by merging three separatedata tools into a single app for guiding decisions at the time of an outbreak.(New York Times)
HPV vaccine is credited in fall of teenagers’ infection rate Theprevalence of dangerous strains of the human papillomavirus (HPV) the mostcommon sexually transmitted infection in the US and a principal cause ofcervical cancer, has dropped by half among teenage girls in recent years, astriking measure of success for a vaccine against the virus that was introducedonly in seven years ago. (New York Times)
Egypt girl’s death puts spotlight on genitial mutilation The deathof a 13-year-old girl during a genital mutilation procedure has brought theissue back into the spotlight in Egypt. While some Egyptians fight for eradicationof the practice, others justify it in on religious grounds. (BBC)
New study tracks emotional health of “surrogate kids” Over thepast decade the number of births involving surrogacy with donor eggs and spermhas surged. What, experts wondered, does this mean for the mental and emotionalhealth of the growing number of kids who may or may not know the truth abouttheir distinctive origins? (Today)
Japan experts mull rules on chimeric embryos Japaneseexperts were on Tuesday set to discuss rules for experiments with animal-humanembryos, as scientists seek permission for tests that could see human organsproduced inside the growing body of an animal. (Fox News) Another news story suggested that human organs could be grown in animalswithin a year. (The Telegraph)
Abortion restrictions in states Forty-onestates have enacted abortion restrictions at different stages of pregnancy. (New York Times)
High court rules ‘pay-for-delay’ drug deals can face antitrustsuits A brand-name drug maker can be sued for violating antitrustlaws if it agrees to pay a potential competitor to delay selling a genericversion, the Supreme Court ruled. (Los Angeles Times)
Be prepared for the big genome leak Mostpeople in the US could soon know someone whose genome is held in a researchdatabase. Concerns are growing about our ability to control access to thatinformation. But many scientists feel that restricting access to genomic datafetters research. How long will it be until an idealistic and technicallyliterate researcher deliberately releases genome and trait information publiclyin the name of open science? (Nature)
Directed in vitro (IVF) technique may increase insulinresistance among offspring A special type of IVF may increase the riskfor insulin resistance among high-tech babies. (E! Science News)
IVF: First baby born using ’safer’ method In aworld first, a healthy baby has been born using a “safer” method of theinfertility treatment IVF, using a natural hormone to kick-start his mother’sovaries. (BBC)
Surrogate Refuses Offer of $10,000 to Abort
Bioethics News
CBHD Academy of Fellows ConsultationShould we be able to create synthetic sperm and eggs for reproductive purposes? Will children born from such procedures be at elevated risk for biological and/or sociological problems?
Explore cutting-edge ethical and theological questions surrounding the development of novel procedures in the artificial creation of human gametes.
Saturday, November 3rd, 2012
10am to 5:30pm
Trinity International University
Kantzer Hall - KANT 141
Admission is free but registration is required
Uruguay’s Senate approved a bill on Wednesday that allows women to have abortions during the first trimester of pregnancy for any reason, opening the way for one of the most sweeping abortion rights laws in Latin America. (New York Times)
Over my dead body
Helping the terminally ill to die, once taboo, is gaining acceptance. (The Economist)
Synthetic biology raises playing God fears
Is it safe to let humans play God and create new organisms - animals and plants - that have never existed in Mother Nature? The ongoing UN Convention on Biodiversity here [Hyderabad] is going to address this question on Friday evening, when it decides if countries need to put their heads together to study the new field of synthetic biology. (Times of India)
California enacts landmark legislation giving same sex parents via surrogacy equal parenting rights
California has taken the unprecedented step of changing the legal definition of “intended parent” to be “an individual, married or unmarried,” making it legislatively illegal to discriminate against same sex parents both before and after their children are born from surrogacy arrangements. (Sacramento Bee)
Blood or bone marrow better for stem cell transplants?
Study found no survival differences, but blood cells may be associated with more chronic side effects.
(U.S. News and World Report)
Stem cells from cadavers? Pluripotent stem cells can be derived from dead bodies, research shows
Death will come for us all one day, but life will not fade from our bodies all at once. After our lungs stop breathing, our hearts stop beating, our minds stop racing, our bodies cool, and long after our vital signs cease, little pockets of cells can live for days, even weeks. Now scientists have harvested such cells from the scalps and brain linings of human corpses and reprogrammed them into stem cells. (Huffington Post)
Shinya Yamanaka interview: 2012 Nobel Prize winner on stem-cells, ethics and the future of medicine
In a conversation with Technology Academy Finland (TAF) at the time of his winning the Millennium Technology Prize earlier this year, and published today exclusively by the Huffington Post, Shinya Yamanaka said a future in which medical drugs are made to order is closer than ever. (Huffington Post)
Should we ration end-of-life care?
A panel debated the pros and cons of both sides in the latest edition of Intelligence Squared U.S. They faced off two against two in an Oxford-style debate on the motion “Ration End-of-Life Care.” (NPR)
Claims of first human stem cell trial unravels
It has been a crazy week for stem cell research. After the high of a Nobel prize for Japan’s Shinya Yamanaka, the pioneer of cellular reprogramming, events took an alarming and surreal turn when a little-known compatriot Hisashi Moriguchi claimed to have already run a clinical trial in which similarly reprogrammed cells were injected into people. (New Scientist)
Tracking a killer: Cell phones aid a pioneering malaria study in Kenya
A pioneering study into malaria transmission in Kenya, using data gleaned from the cell phones of nearly 15 million people, has given scientists new clues into how the deadly disease spreads. (CNN)
Bioethics In the News
A new fertility-treatment study has found that women who receive three or more embryos have no better odds of giving birth than those who receive only two embryos. (Washington Post)
FDA Warning: About Illegal Stem Cell Treatments
The FDA announced this week that patients' hopes for cures leave them vulnerable prey for providers of illegal and potentially harmful stem cell treatments. (Medical Daily)
Surrogacy: A Growing International Injustice
International surrogacy is a growing business thanks to Westerners hiring poor women in developing countries to carry their babies. But media attention could change that. (Slate)
Skipping the Banks, Making Online Deals
Women are increasingly making online connections with men willing to donate sperm for free, skirting the expensive option of using a sperm bank with all its regulations, tests, and verifications. (ABC News)
Here are three news stories of interest relating to the fertility industry:
The government of India proposes womb banks to legalize surrogacy.
Women using ARTS who are overweight have a sharply increased miscarriage rate
Donor conception: An increasing number of men offer their sperm (and/or bodies) online for insemination, skirting regulation